He said Indian pharma companies have secured 31% of the market authorizations granted by USFDA in 2019 -20, which shows that Indian companies continue to be able to introduce new products.from Economy-News-Economic Times https://ift.tt/2FZvCok
Monday, September 21, 2020
Tariff, non-tariff measures to protect India's interests: Piyush Goyal
He said Indian pharma companies have secured 31% of the market authorizations granted by USFDA in 2019 -20, which shows that Indian companies continue to be able to introduce new products.from Economy-News-Economic Times https://ift.tt/2FZvCok
Subscribe to:
Post Comments (Atom)
-
While the Nikkei Manufacturing Purchasing Managers' Index , compiled by IHS Markit, increased to 47.2 last month from 30.8 in May it was...
-
But unlike the most relief packages announced globally, Rs 20 lakh crore is not entirely in new spending and includes Rs 1.7 lakh crore pack...
-
The overall export of oilmeals during April 2020 to March 2021 increased sharply and provisionally reported at 3,680,084 tons compared to 2,...
No comments:
Post a Comment